Tower Research Capital (TRC)’s Eloxx Pharmaceuticals ELOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.76K Buy
+507
New +$7.84K ﹤0.01% 4444

Other funds holding ELOX

Tower Research Capital (TRC)'s ELOX Position: Q3 2026 in Review

Tower Research Capital (TRC) opened a new position in Eloxx Pharmaceuticals (ELOX) in Q3 2026: 507 shares worth $7.76K. The stake represents ﹤0.01% of the portfolio and ranks #4444 among its holdings.

20 funds tracked by Wall St. Rank hold ELOX as of Q3 2026.

  • Tower Research Capital (TRC) held 507 shares of Eloxx Pharmaceuticals worth $7.76K as of Q3 2026.
  • Eloxx Pharmaceuticals was a new Tower Research Capital (TRC) position in Q3 2026.
  • Eloxx Pharmaceuticals made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4444 holding.
  • 20 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.